FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD‐L1

出版年份 2018 全文链接

标题

作者

关键词

出版物

Volume -, Issue -, Pages theoncologist.2018-0221

出版商

Alphamed Press

发表日期

2018-08-17

DOI

10.1634/theoncologist.2018-0221

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now